HTEC to Support Digital Telco Enabler Telness Tech in Platform Software Development
17.9.2024 19:31:00 EEST | Business Wire | Press release
Telness Tech, a fast-growing international software company founded in Sweden, and HTEC, a global end-to-end digital product development and engineering services company, are pleased to announce their work on Telness Tech’s innovative platform, which will support the company’s ongoing expansion into new markets, like the US.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917678716/en/
In this partnership, HTEC will support Telness Tech by providing additional engineering expertise for the new platform’s deployment, customization, and user migration from legacy platforms. HTEC will also assist in the development of business-to-consumer (B2C) applications and various network integrations, including building an abstraction layer for easier integrations. (Graphic: Business Wire)
The platform’s proprietary software is a cloud-based, end-to-end solution for mobile virtual network operators (MVNOs) that offers comprehensive operations and business support system (OSS/BSS) capabilities. It streamlines and automates the customer journey, deploying quickly and remotely without the need for traditional telco infrastructure or legacy IT systems. The platform has already helped Telness Tech clients boost customer ratings in Europe.
In the partnership, HTEC will support Telness Tech by providing additional engineering expertise for the new platform’s deployment, customization, and user migration from legacy platforms. HTEC will also assist in the development of business-to-consumer (B2C) applications and various network integrations, including building an abstraction layer for easier integrations.
Commenting on the collaboration, HTEC’s Director of Engineering & Delivery Bojan Šukalo said:
“Recent tech innovations have transformed how we communicate, but many in the telco industry still use traditional infrastructure. With HTEC’s technical expertise and engineering capacity, we’re perfectly positioned to support the industry’s digital transformation and aligned with Telness Tech to steer the industry forward.”
Founder and COO of Telness Tech, Jonas Cedenwing, highlighted the value of HTEC’s support in this expansion:
“With high demand for our software across the globe, partnering with HTEC ensures that our clients’ platform demands and transitions remain smooth and streamlined, enabling us to continue our high expansion rate without compromising quality.”
About Telness Tech
Founded in Sweden with offices in the US, Telness Tech provides everything needed to launch or run a fully automated mobile operator. The company’s end-to-end BSS/OSS solutions streamline customer journeys, provisioning, and porting — necessary functions to run a digital mobile operator. As a result, satisfied clients drastically reduce operational costs.
About HTEC
HTEC Group Inc. is a global premium technology services firm powering the technological evolution of the world’s most impactful organizations—from disruptive startups to the Fortune 500. HTEC combines deep engineering expertise with remarkable creativity, enabling its customers to innovate, design, and develop disruptive technologies and new digital solutions across different industries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240917678716/en/
Contacts
HTEC Media Relations: media@htecgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release
Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti
Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release
Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release
4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release
4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a
LTM Wins Two Google Cloud Partner of the Year Awards for 202622.4.2026 05:30:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, announced today that it has received two Google Cloud Partner of the Year 2026 Awards. LTM is being recognized for its achievements in the Google Cloud ecosystem, helping joint customers to drive high-impact, scalable cloud transformations. LTM won the Google Cloud Partner of the Year Award in the Media & Entertainment category by modernizing a global media company's complex data estate with BigQuery. The transformation improved speed, lowered costs, and provided a scalable foundation, enabling real-time analytics and AI-ready pipelines. This approach offers a repeatable model for data modernization in Media and Entertainment industry. Additionally, LTM was honoured with another Google Cloud Partner of the Year Award for Infrastructure Modernization in North America and the transformation of the ERP landscape for a global leader in healthcare services. This resulted in faster time to market, modern scalable ecosys
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom